View:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.) *
Eagle Pharmaceuticals Inc.
(Name of Issuer)
Common Shares
(Title of Class of
Securities)
269796108
(CUSIP Number)
December 31, 2023
(Date of Event Which Requires Filing of this
Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[x] Rule 13d-1 (b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
persons initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of
that section of the ACT but shall be subject to all other provisions of
the Act (however, see the Notes).
SEC 1745 (3-98)
CUSIP No.269796108
1.
Names of Reporting
Persons.
Brandes Investment Partners, L.P.
I.R.S. Identification Nos. of above
persons (entities only).
33-0704072
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) 0
(b) 0
3.
SEC Use Only
4.
Citizenship or Place of
Organization
Delaware
Number of Shares Beneficially owned by Each
Reporting Person With:
5.
Sole Voting Power
6.
Shared Voting Power
299,235
7.
Sole Dispositive
Power
8.
Shared Dispositive
Power
745,079
9.
Aggregate Amount Beneficially Owned by Each
Reporting Person
745,079
10.
Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions)
0
11.
Percent of Class Represented by
Amount in Row (9)
5.74 %
12.
Type of Reporting Person (See
Instructions)
IA, PN
CUSIP No.269796108
1.
Names of Reporting
Persons.
CO-GP, LLC
I.R.S. Identification Nos. of above
persons (entities only).
73-1677697
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) 0
(b) 0
3.
SEC Use Only
4.
Citizenship or Place of
Organization
Delaware
Number of Shares Beneficially owned by Each
Reporting Person With:
5.
Sole Voting Power
6.
Shared Voting Power
299,235
7.
Sole Dispositive
Power
8.
Shared Dispositive
Power
745,079
9.
Aggregate Amount Beneficially Owned by Each
Reporting Person
745,079 shares are deemed to be
beneficially owned by CO-GP, LLC
as a control person of the
investment adviser. CO-GP, LLC
disclaims any direct ownership
of the shares reported in this
Schedule 13G, except for an
amount that is substantially
less than one per cent of the
number of shares reported
herein.
10.
Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions)
0
11.
Percent of Class Represented by Amount
in Row (9)
5.74 %
12.
Type of Reporting Person (See
Instructions)
CO, OO (Control
Person)
CUSIP No.269796108
1.
Names of Reporting
Persons.
Brandes Worldwide Holdings, L.P.
I.R.S. Identification Nos. of above persons (entities
only).
33-0836630
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) 0
(b) 0
3.
SEC Use Only
4.
Citizenship or Place of
Organization
Delaware
Number of Shares Beneficially owned by Each
Reporting Person With:
5.
Sole Voting Power
6.
Shared Voting Power
299,235
7.
Sole Dispositive
Power
8.
Shared Dispositive
Power
745,079
9.
Aggregate Amount Beneficially Owned by Each
Reporting Person
745,079 shares are deemed to be
beneficially owned by Brandes
Worldwide Holdings, L.P., as a
control person of the
investment adviser. Brandes
Worldwide Holdings, L.P.
disclaims any direct ownership
of the shares reported in this
Schedule 13G.
10.
Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions)
0
11.
Percent of Class Represented by
Amount in Row (9)
5.74 %
12.
Type of Reporting Person (See
Instructions)
PN, OO (Control
Person)
CUSIP No.269796108
1.
Names of Reporting
Persons.
Glenn Carlson
I.R.S. Identification Nos. of above persons (entities
only).
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) 0
(b) 0
3.
SEC Use Only
4.
Citizenship or Place of
Organization
USA
Number of Shares Beneficially owned by Each
Reporting Person With:
5.
Sole Voting Power
6.
Shared Voting Power
299,235
7.
Sole Dispositive
Power
8.
Shared Dispositive
Power
745,079
9.
Aggregate Amount Beneficially Owned by Each
Reporting Person
745,079 shares are deemed to be
beneficially owned by Glenn
Carlson, a control person of
the investment adviser. Mr.
Carlson disclaims any direct
ownership of the shares
reported in Schedule 13G,
except for the amount that is
substantially less than one per
cent of the number of shares
reported herein.
10.
Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions)
0
11.
Percent of Class Represented by
Amount in Row (9)
5.74 %
12.
Type of Reporting Person (See
Instructions)
IN, OO (Control
Person)
Item 1(a) Name of Issuer:
Eagle Pharmaceuticals Inc.
Item 1(b) Address of Issuers Principal Executive
Offices:
50 Tice Boulevard, Suite 315, Woodcliff
Lake, NJ 07677
Item 2(a) Name of Person Filing:
(i) Brandes Investment Partners, L.P.
(ii) CO-GP, LLC.
(iii) Brandes Worldwide Holdings, L.P.
(iv) Glenn Carlson
Item 2(b) Address of Principal Business office or,
if None, Residence:
(i) 4275 Executive Square, 5th Floor, La
Jolla, CA 92037
(ii) 4275 Executive Square, 5th Floor, La
Jolla, CA 92037
(iii) 4275 Executive Square, 5th Floor,
La Jolla, CA 92037
(iv) 4275 Executive Square, 5th Floor, La
Jolla, CA 92037
Item 2(c) Citizenship
(i) Delaware
(ii) Delaware
(iii) Delaware
(iv) USA
Item 2(d) Title of Class Securities:
Common Shares
Item 2(e) CUSIP Number:
269796108
Item 3. If this statement is filed pursuant to
240.13d-1(b), or 240.13d-2(b) or (c), check
whether the person filing is a:
(a) [ ] Broker or dealer registered under
section 15 of the Act (15 U.S.C.
78o).
(b) [ ] Bank as defined in section 3(a)(6)
of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in
section 3(a)(19) of the Act (15
U.S.C. 78c).
(d) [ ] Investment company registered under
section 8 of the Investment Company
Act (15 U.S.C. 80a-8).
(e) [ ] An investment adviser in accordance
with 240.13d-1(b)(1)(ii)(E).
(f) [ ] An employee benefit plan or
endowment fund in accordance with
240.13d-1(b)(ii)(F).
(g) [ ] A parent holding company or control
person in accordance with 240.13d-
1(b)(1)(ii)(G).
(h) [ ] A savings association as defined in
Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813).
(i) [ ] A church plan that is excluded from
the definition of an investment
company under section 3(c)(14) of
the Investment Company Act of 1940
(15 U.S.C. 80a-3).
(j) [x] Group, in accordance with 240.13d-
1(b)(1)(ii)(J).
This statement is filed by Brandes
Investment Partners, L.P., an investment
adviser registered under the Investment
Advisers Act of 1940, its control persons
and its holding company. (See, also,
Exhibit A.)
Item 4. Ownership:
(a) Amount Beneficially Owned: 745,079
(b) Percent of Class: 5.74 %
(c) Number of shares as to which the joint
filers have:
(i) sole power to vote or to direct the
vote: 0
(ii) shared power to vote or to direct
the vote: 299,235
(iii) sole power to dispose or to
direct the disposition of:
0
(iv) shared power to dispose or to
direct the disposition of: 745,079
Item 5. Ownership of Five Percent or Less of a
Class.
If this statement is being filed to report
the fact that as of the date hereof the
reporting person has ceased to be the
beneficial owner of more than five percent
of the class securities, check the following
?. N/A
Item 6. Ownership of More than Five Percent on
Behalf of Another Person. N/A
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members
of the Group.
See Exhibit A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certification:
(a) The following certification shall be
included if the statement is filed
pursuant to 240.13d-1(b):
By signing below I certify that, to the
best of my knowledge and belief, the
securities referred to above were
acquired and held in the ordinary course
of business and were not acquired and
are not held for the purpose of or with
the effect of changing or influencing
the control of the issuer of the
securities and were not acquired and are
not held in connection with or as a
participant in any transaction having
that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information
set forth in this statement is true, complete and
correct.
Date: February 8, 2024
BRANDES INVESTMENT
PARTNERS, L.P.
By: /s/ Glenn Carlson
Glenn Carlson,
General Partner
CO-GP, LLC its
General Partner
CO-GP, LLC
By: /s/ Glenn Carlson
Glenn Carlson,
General Partner
BRANDES WORLDWIDE
HOLDINGS, L.P.
By: /s/ Glenn Carlson
Glenn Carlson of CO-
GP, LLC its General
Partner
By: /s/ Glenn Carlson
Glenn Carlson,
Control Person
EXHIBIT A
Identification and Classification of Members of the
Group
Pursuant to Rule 13d-1(b)(ii)(J) and Rule 13d-1(k)(1)
under the Securities and Exchange Act of 1934, the
members of the group making this joint filing are
identified and classified as follows:
Name: Brandes Investment Partners, L.P.
(the Investment Adviser)
Classification: Investment adviser registered under
Investment Advisers Act of 1940
Co-GP, LLC
A control person of the Investment
Adviser
Brandes Worldwide Holdings, L.P.
A control person of the Investment
Adviser
Glenn Carlson
A control person of the Investment
Adviser
EXHIBIT B
Joint Filing Agreement Pursuant to Rule 13d-1
This agreement is made pursuant to Rule 13d-
1(b)(ii)(J) and Rule 13d-1(k)(1) under the Securities
and Exchange Act of 1934 (the Act) by and among the
parties listed below, each referred to herein as a
Joint Filer. The Joint Filers agree that a statement
of beneficial ownership as required by Sections 13(g)
or 13(d) of the Act and the Rules thereunder may be
filed on each of their behalf on Schedule 13G or
Schedule 13D, as appropriate, and that said joint
filing may thereafter be amended by further joint
filings. The Joint Filers state that they each
satisfy the requirements for making a joint filing
under Rule 13d-1.
Dated: February 8, 2024
BRANDES INVESTMENT
PARTNERS, L.P.
By: /s/ Glenn Carlson
Glenn Carlson,
General Partner of
Co-GP, LLC.
Co-GP, LLC.
By: /s/ Glenn Carlson
Glenn Carlson,
General Partner
EXHIBIT C
Disclaimer of Beneficial Ownership
Co-GP, LLC, Brandes Worldwide Holdings, L.P., Glenn
Carlson, and Jeff Busby disclaim beneficial interest
as to the shares referenced above, except for an
amount equal to substantially less than one percent
of the shares reported on this Schedule 13D. None of
these entities or individuals holds the above-
referenced shares for its/his own account except on a
de minimis basis.
/s/Glenn Carlson
Glenn Carlson
/s/Jeff Busby
Jeff Busby